Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension

by Ysios Capital

It has been announced today the positive topline data from its pivotal Launch-HTN Phase 3 and pivotal Advance-HTN Phase 2 trials evaluating the efficacy and safety of lorundrostat for the treatment of...

Read more

Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients

by Laminar Pharma

The trial, partially funded with an EU H2020 Grant (ClinGlio), has shown an improvement trend in progression-free survival (PFS) in MGMT-methylated patients receiving LAM561 in combination with chemor...

Read more

Desarrollan un antiviral de amplio espectro basado en una sustancia del caparazón de los crustáceos

by CSIC - Centro Superior de Investigaciones Científicas

Varios centros del CSIC colaboran en el desarrollo de un compuesto eficaz frente a infecciones respiratorias virales como el coronavirus SARS-CoV-2 y el virus respiratorio sincitial

Read more

ICH Guidelines: Drug Stability Testing Essentials

by AMSbiopharma

The ICH, a non-profit international organization founded in 1990, developed the ICH guidelines as scientific consensus documents. The ICH guidelines full form stands for the International Council for ...

Read more

Asabys invests in €77.7 million round of Augustine Therapeutics

by Asabys Partners

Augustine Therapeutics, focused on developing new therapies for neuromuscular, neurodegenerative and cardio-metabolic diseases through the inhibition of the cytosolic Histone DeACetylase 6 (HDAC6) enz...

Read more

Cómo las CROs facilitan la puesta en marcha de ensayos clínicos: desde la planificación hasta la ejecución

by Sermes CRO

Las CROs (Organizaciones de Investigación por Contrato) desempeñan un papel esencial en la puesta en marcha y ejecución de ensayos clínicos. Desde la planificación inicial hasta la ejecución fin...

Read more

New pathways discovered for drugs to act on cells

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Previously unknown access points in cell membrane proteins have been discovered, enabling laboratory-developed drugs to modify cell function.

Read more

Aromics joins the BME Pre-Market Environment

by AROMICS

The company develops innovative compounds that that RNA of cancer-driven genes. Its lead compound, currently advancing into the clinical phase, targets the treatment of malignant mesothelioma, a disea...

Read more

Gain Therapeutics announces the administration of its drug GT-02287 to first patient in phase 1b clinical trial for Parkinson’s disease

by Parc Científic de Barcelona

The clinical-stage biotechnology company, Gain Therapeutics, has announced the administration of the first dose to a participant with Parkinson’s disease in its phase 1b clinical trial of GT-02287, ...

Read more

UB researchers develop a new compound with therapeutic potential against Alzheimer’s disease

by Universitat de Barcelona

The new compound is an inhibitor of soluble epoxide hydrolase (sEH), an enzyme involved in the regulation of several physiological processes, including inflammation and pain response. In the context o...

Read more

Desarrollan unas gotas oculares como posible terapia para la retinosis pigmentaria

by Professional Newco

Este enfoque no invasivo consiste en gotas oftálmicas cargadas con el anticuerpo monoclonal adalimumab (ADA), dirigido contra la citoquina TNFα, involucrada en la inflamación de la retina.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream